UK markets closed

Merck & Co., Inc. (6MK.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
121.80-0.60 (-0.49%)
At close: 05:35PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 305.47B
Enterprise value 331.56B
Trailing P/E 145.01
Forward P/E 15.15
PEG ratio (5-yr expected) 0.10
Price/sales (ttm)5.41
Price/book (mrq)8.80
Enterprise value/revenue 5.40
Enterprise value/EBITDA 67.62

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 313.20%
S&P500 52-week change 323.10%
52-week high 3124.40
52-week low 391.00
50-day moving average 3117.10
200-day moving average 3105.09

Share statistics

Avg vol (3-month) 3958
Avg vol (10-day) 3576
Shares outstanding 52.53B
Implied shares outstanding 62.57B
Float 82.53B
% held by insiders 10.05%
% held by institutions 178.44%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.84
Forward annual dividend yield 42.33%
Trailing annual dividend rate 32.96
Trailing annual dividend yield 32.42%
5-year average dividend yield 42.89
Payout ratio 4333.33%
Dividend date 3N/A
Ex-dividend date 414 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.76%
Operating margin (ttm)38.54%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)61.4B
Revenue per share (ttm)24.22
Quarterly revenue growth (yoy)8.90%
Gross profit (ttm)N/A
EBITDA 10.36B
Net income avi to common (ttm)2.31B
Diluted EPS (ttm)0.84
Quarterly earnings growth (yoy)68.80%

Balance sheet

Total cash (mrq)7.09B
Total cash per share (mrq)2.8
Total debt (mrq)36.27B
Total debt/equity (mrq)96.37%
Current ratio (mrq)N/A
Book value per share (mrq)14.85

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A